Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 268 | 274 | 193 | 0 | 0 |
| Gross Profit | 268 | 274 | 193 | N/A | N/A |
| Operating Expenses | 3,532 | 5,027 | 3,998 | 4,221 | 4,103 |
| Operating Income | -3,264 | -4,753 | -3,805 | -4,221 | -4,103 |
| Other Income | 102 | -73 | 78 | -89 | 119 |
| Pre-tax Income | -3,162 | -4,826 | -3,727 | -4,310 | -3,984 |
| Income Tax | N/A | 0 | 105 | 1 | N/A |
| Net Income Continuous | -3,162 | -4,826 | -3,832 | -4,311 | -3,984 |
| Net Income | $-3,162 | $-4,826 | $-3,832 | $-4,311 | $-3,984 |
| EPS Basic Total Ops | -46.80 | -71.99 | -61.19 | -70.19 | -64.79 |
| EPS Basic Continuous Ops | -46.78 | -71.89 | -61.86 | -69.90 | -64.60 |
| EPS Diluted Total Ops | -46.80 | -71.99 | -61.19 | -70.19 | -64.79 |
| EPS Diluted Continuous Ops | -46.78 | -71.89 | -61.86 | -69.90 | -64.60 |
| EBITDA(a) | $-3,344 | $-4,676 | $-3,770 | $-4,090 | $-4,133 |